BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15955630)

  • 1. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
    Costa-Mallen P; Costa LG; Checkoway H
    Neurosci Lett; 2005 Sep; 385(2):158-62. PubMed ID: 15955630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.
    Wang TJ; Huang SY; Lin WW; Lo HY; Wu PL; Wang YS; Wu YS; Ko HC; Shih JC; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):108-14. PubMed ID: 17007976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
    Pivac N; Knezevic J; Kozaric-Kovacic D; Dezeljin M; Mustapic M; Rak D; Matijevic T; Pavelic J; Muck-Seler D
    J Affect Disord; 2007 Nov; 103(1-3):131-8. PubMed ID: 17289152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.
    Costa-Mallen P; Costa LG; Smith-Weller T; Franklin GM; Swanson PD; Checkoway H
    J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):535-7. PubMed ID: 10990520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men.
    Pivac N; Knezevic J; Mustapic M; Dezeljin M; Muck-Seler D; Kozaric-Kovacic D; Balija M; Matijevic T; Pavelic J
    Life Sci; 2006 May; 79(1):45-9. PubMed ID: 16427095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population.
    Gassó P; Bernardo M; Mas S; Crescenti A; Garcia C; Parellada E; Lafuente A
    Neuropsychobiology; 2008; 58(2):65-70. PubMed ID: 18832861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the association between smoking behavior and dopamine receptor D2 gene polymorphisms among lung cancer cases].
    Qi J; Tan W; Xing D; Miao X; Lin D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Oct; 23(5):370-3. PubMed ID: 12482370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
    Tochigi M; Suzuki K; Kato C; Otowa T; Hibino H; Umekage T; Kato N; Sasaki T
    Pharmacogenet Genomics; 2007 Oct; 17(10):867-72. PubMed ID: 17885625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese.
    Yoshida K; Hamajima N; Kozaki Ki ; Saito H; Maeno K; Sugiura T; Ookuma K; Takahashi T
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):403-5. PubMed ID: 11319183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidases A and B gene polymorphisms in migraine patients.
    Filic V; Vladic A; Stefulj J; Cicin-Sain L; Balija M; Sucic Z; Jernej B
    J Neurol Sci; 2005 Feb; 228(2):149-53. PubMed ID: 15694196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.
    Vandenbergh DJ; O'Connor RJ; Grant MD; Jefferson AL; Vogler GP; Strasser AA; Kozlowski LT
    Addict Biol; 2007 Mar; 12(1):106-16. PubMed ID: 17407504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.
    Wiesbeck GA; Dürsteler-MacFarland KM; Wurst FM; Walter M; Petitjean S; Müller S; Wodarz N; Böning J
    Addict Biol; 2006 Mar; 11(1):72-5. PubMed ID: 16759339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans.
    Konishi T; Calvillo M; Leng AS; Lin KM; Wan YJ
    Alcohol; 2004 Jan; 32(1):45-52. PubMed ID: 15066703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.
    Huang SY; Lin WW; Wan FJ; Chang AJ; Ko HC; Wang TJ; Wu PL; Lu RB
    J Psychiatry Neurosci; 2007 May; 32(3):185-92. PubMed ID: 17476365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
    Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.
    Johnstone EC; Yudkin P; Griffiths SE; Fuller A; Murphy M; Walton R
    Addict Biol; 2004; 9(3-4):221-6. PubMed ID: 15511716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders.
    Cusin C; Serretti A; Lattuada E; Lilli R; Lorenzi C; Smeraldi E
    Am J Med Genet; 2002 May; 114(4):380-90. PubMed ID: 11992560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.
    Gemignani F; Landi S; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; Cambray M; Capellà G; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1633-8. PubMed ID: 16030094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
    Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y
    Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.
    Zappia M; Annesi G; Nicoletti G; Arabia G; Annesi F; Messina D; Pugliese P; Spadafora P; Tarantino P; Carrideo S; Civitelli D; De Marco EV; Cirò-Candiano IC; Gambardella A; Quattrone A
    Arch Neurol; 2005 Apr; 62(4):601-5. PubMed ID: 15824260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.